Phase 3 BELLWAVE-010: Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab (VR) in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Lavie D., ÖZCAN M., Chaudhry A., Zhou X., Paydar I., Farooqui M. Z. H., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Publication Date: 2024
• Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Ankara University Affiliated: Yes